David Beier

Patients facing terminal illness deserve respect and medicines that work. We need to do better. Here's how: #245ff5fc19ab" target="_blank" rel="nofollow noopener">forbes.com/sites/realspin…

Why we need a new federal and state compact on AI. See link below. Here I argue that full bore federal preemption of State law is bad policy and legally suspect. But I point to a better way in which the federal government government does have hegemony (e.g. defense, Bioweapons, cybersecurity) and some topics where states keep jurisdiction like traditional negligence and fraud. Finding the right balance on AI regulation requires more than bumper sticker level political posturing. Rather Congress and the States need to do the hard work of fact finding, listening, learning and legislating in the daylight. I hope you enjoy this piece. theregreview.org/2026/01/12/bei… America faces two critical AI policy questions: Should federal regulation preempt state laws? And how do we govern the massive data centers powering AI expansion? The answer requires rejecting false choices. We can lead in AI development while maintaining strong safeguards—but not through executive overreach or industry self-regulation. Presidential executive orders cannot legally nullify state laws without explicit congressional authorization. States possess constitutional police powers over public safety, consumer protection, electricity rates, and water usage. With trillions in data center investment planned, we need state expertise managing local grid impacts, water supplies, and community effects—experience states like Virginia have already demonstrated. The federal government should lead on national security, cybersecurity, and safety standards for large AI systems. California’s SB 53 offers a model: legally binding checkpoints less burdensome than European rules, focused on high-risk systems. Congress must enact comprehensive legislation through open hearings and public deliberation, not backroom deals. This preserves democratic governance while keeping America competitive. AI will transform society. Whether it serves broad public interests or narrow corporate gains depends on governance choices we make now. We have one chance to get this right.

The US is falling behind in artificial intelligence research thehill.com/opinion/techno… by Senator Tom Daschle and David Beier

Like the brand tumi.com/p/continental-…

Managing Director of Bay City Capital, David Beier (@beier_dbeier) joins our Board of Directors, bringing a deep understanding of health care policy and program implementation.

Had an awesome opportunity today to give the Stanford Infectious Disease Grand Rounds, covering our journey over the past ~2 years working to improve public respiratory protection. Thankful for many, but esp @RanuDhillon @sri_srikrishna @beier_dbeier @larmbrust @FixTheMask

Little Hoover Commission: 2021 Year in Review: mailchi.mp/22bb742cf332/l…

@ASlavitt What about ‘ism’ title: PUBLIC HEALTH IGNORED: 600,000 DIE

By the way, that’s just a working title. If you have other suggestions as to good titles to represent the other side, please suggest!

I just read a lengthy op-ed review of #PREVENTABLE. It noticed that I did not provide both sides of the argument. Fair. So I will write a second book: “Covid-19: the untold story of why I like your blood vessels.” But if you prefer the first one: read.macmillan.com/promo/smppreve…

@ASlavitt Terrific book. A narrative of hope, frustration, and serious “preventable” errors on COVID. Andy’s prescription for policy changes —Plan N as in Never — in the Appendix may seem idealistic, unless you read this book. He puts you ‘in the room where it happened’.

On sale today. My longest tweet. us.macmillan.com/preventable/an…

@bobkocher A good place to look for suggestions on where and how to improve the US health care scheme (not really a system can be found in Andy Slavitt’s brilliant new book, Preventable, a bird’s eye view of COVID. See Appendix, Exhibit N.

Thank goodness. Now let’s all put our efforts into making healthcare more affordable, more consistently high quality, and more accessible!

@hmkyale @bfrist When Congressional committees in the House and Senate take up science infrastructure legislation this week the promising news is that it is bipartisan.

Pleased to be part of this piece: 'Science: The Vital Piece of the Jobs Plan That Should be Bipartisan’ w/ @bfrist @beier_dbeier … ‘[Biden plan] invests hundreds of billions in R and D to create healthier climate, better health & high-quality jobs.’ davidbeier.medium.com/science-the-vi…

Sound advice of masks and vaccines. Thx Dr. Karan.

The idea that all Americans deserve better masks is common sense.

It seems silly to suggest wearing 2 masks — when better masks exist. We should get every American better masks since vaccination is going to take a long time! washingtonpost.com/outlook/2021/0…

Here is what @davidbeier and I think we must do to prepare for the next pandemic: 1. Antitrust carve-outs 2. Biotech infrastructure bank 3. Research and development funds 4. Standby pandemic manufacturing 5. Access to pandemic and other medicines biocentury.com/article/633815

CNN Opinion: America needs more N95 masks to fight Covid-19 cnn.com/2021/01/29/opi…

@JanNWolfe @JonathanTurley @steve_vladeck @CBHessick Turkey's entire career has been a desperate attempt to run to the head of the parade of whatever newsworthy event to scream "I am the ... lawyer" and then to sell snake oil legal "insight" to the nearest TV show. I call it shilling for fame.

@ASlavitt The single best health appointment yet. Thank you Andy. Washington DC needs you.

On Jan 20, I will join the new White House team on a short term basis as Senior Advisor for COVID response. These are relatively new plans. I will tweet separately about the great plans for some of the other things I have been working on while I do this.

@TomBollyky I very appreciate appreciate the triage arguments for 1 dose but I have two concerns. When there is insufficient evidence to support it could adversely affect vaccine confidence. We built a public health infrastructure at the FDA, CDC and NIH we should not undermine them.

A single-dose regimen that offers less protection from COVID-19 may alleviate supply constraints w/ 2-dose vaccine But it does so at expense of aggravating demand & administration constraints that are greater hurdle to vaccinating vulnerable groups in US acpjournals.org/doi/10.7326/M2…